Skip to main content
Journal cover image

CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL

Publication ,  Conference
Thompson, E; Landi, D; Lipp, E; Balajonda, B; Herndon, J; Buckley, E; Flahiff, C; Jaggers, D; Schroeder, K; Randazzo, D; Desjardins, A ...
Published in: Neuro-Oncology
November 9, 2020

Duke Scholars

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 9, 2020

Volume

22

Issue

Supplement_2

Start / End Page

ii37 / ii37

Publisher

Oxford University Press (OUP)

Conference Name

2020 Society for Neuro-Oncology’s Virtual Annual Scientific Meeting and Education Day

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, E., Landi, D., Lipp, E., Balajonda, B., Herndon, J., Buckley, E., … Sampson, J. (2020). CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In Neuro-Oncology (Vol. 22, pp. ii37–ii37). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaa215.155
Thompson, Eric, Daniel Landi, Eric Lipp, Bea Balajonda, James Herndon, Evan Buckley, Charlene Flahiff, et al. “CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In Neuro-Oncology, 22:ii37–ii37. Oxford University Press (OUP), 2020. https://doi.org/10.1093/neuonc/noaa215.155.
Thompson E, Landi D, Lipp E, Balajonda B, Herndon J, Buckley E, et al. CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In: Neuro-Oncology. Oxford University Press (OUP); 2020. p. ii37–ii37.
Thompson, Eric, et al. “CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” Neuro-Oncology, vol. 22, no. Supplement_2, Oxford University Press (OUP), 2020, pp. ii37–ii37. Manual, doi:10.1093/neuonc/noaa215.155.
Thompson E, Landi D, Lipp E, Balajonda B, Herndon J, Buckley E, Flahiff C, Jaggers D, Schroeder K, Randazzo D, Desjardins A, Johnson M, Peters K, Khasraw M, Malinzak M, Mitchell D, Ashley D, Sampson J. CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. Neuro-Oncology. Oxford University Press (OUP); 2020. p. ii37–ii37.
Journal cover image

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 9, 2020

Volume

22

Issue

Supplement_2

Start / End Page

ii37 / ii37

Publisher

Oxford University Press (OUP)

Conference Name

2020 Society for Neuro-Oncology’s Virtual Annual Scientific Meeting and Education Day

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences